Holen Sie sich die Stockscreener-App
9.61
2.54%
-0.25
Vorhandelsmarkt:
9.64
0.03
+0.31%
Schlusskurs vom Vortag:
$9.86
Offen:
$9.73
24-Stunden-Volumen:
180.94K
Relative Volume:
0.66
Marktkapitalisierung:
$211.45M
Einnahmen:
$52.55M
Nettoeinkommen (Verlust:
$-23.69M
KGV:
-10.22
EPS:
-0.94
Netto-Cashflow:
$-15.29M
1W Leistung:
-2.93%
1M Leistung:
+11.36%
6M Leistung:
+177.75%
1J Leistung:
+222.48%
1-Tages-Spanne:
$9.55
$10.00
1-Wochen-Bereich:
$9.45
$10.00
52-Wochen-Spanne:
$2.38
$10.34
Exagen Inc Stock (XGN) Company Profile
Firmenname
Exagen Inc
Sektor
Branche
Telefon
(760) 560-1501
Adresse
1261 LIBERTY WAY, VISTA, CA
Vergleichen Sie XGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
9.61 | 216.96M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
487.53 | 186.06B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
203.79 | 147.38B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
639.45 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
125.21 | 35.62B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
183.74 | 32.44B | 15.70B | 1.24B | 2.01B | 6.91 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-30 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-23 | Eingeleitet | Craig Hallum | Buy |
| 2022-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-04-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-06-02 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cowen | Outperform |
| 2019-10-14 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Exagen Inc Aktie (XGN) Neueste Nachrichten
Intraday pattern recognizer results for Exagen Inc.Quarterly Market Review & Momentum Based Trading Signals - Newser
Exagen Inc. stock momentum explainedWeekly Gains Report & Verified Momentum Stock Alerts - Newser
Exagen Inc. stock trend forecast2025 Stock Rankings & Free Verified High Yield Trade Plans - Newser
Real time pattern detection on Exagen Inc. stock2025 Trading Volume Trends & Daily Growth Stock Tips - Newser
Can Exagen Inc. Regain Momentum After Breakdown getLinesFromResByArray error: size == 0 - thegnnews.com
How to forecast Exagen Inc. trends using time series2025 Top Gainers & Community Verified Trade Signals - Newser
Tools to assess Exagen Inc.’s risk profile2025 Market Outlook & Expert Curated Trade Setups - Newser
Using AI based signals to follow Exagen Inc.Portfolio Value Summary & Weekly Watchlist of Top Performers - Newser
Smart tools for monitoring Exagen Inc.’s price actionPortfolio Growth Summary & Expert Approved Momentum Ideas - Newser
Can technical indicators confirm Exagen Inc.’s reversalEarnings Summary Report & Daily Momentum Trading Reports - Newser
What’s the analyst consensus on Exagen Inc.July 2025 Sentiment & Verified Entry Point Detection - خودرو بانک
What the charts say about Exagen Inc. todayM&A Rumor & Community Trade Idea Sharing Platform - Newser
Is Exagen Inc. exposed to political risk2025 Dividend Review & Low Risk Investment Opportunities - خودرو بانک
Using R and stats models for Exagen Inc. forecastingExit Point & Entry Point Confirmation Signals - Newser
Volume spikes in Exagen Inc. stock – what they meanGap Up & Weekly Chart Analysis and Trade Guides - Newser
What risks could impact Exagen Inc. stock performance2025 Top Gainers & Daily Chart Pattern Signal Reports - Newser
Will Exagen Inc. benefit from AI trendsJuly 2025 Outlook & Reliable Trade Execution Plans - خودرو بانک
Exagen Inc.’s Beta Climbs After Market Volatility getLinesFromResByArray error: size == 0 - thegnnews.com
Is It Too Late to Sell Exagen Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Will Exagen Inc. price bounce be sustainableForecast Cut & AI Driven Stock Movement Reports - Newser
Fibonacci Retracement Aligns with Support in Exagen Inc.Market Growth Summary & AI Optimized Trading Strategy Guides - beatles.ru
Risk adjusted return profile for Exagen Inc. analyzedBuy Signal & Low Risk High Reward Ideas - Newser
Is Exagen Inc. stock reversal real or fakeMarket Activity Report & Safe Capital Allocation Plans - Newser
Market reaction to Exagen Inc.’s recent news2025 Biggest Moves & Safe Swing Trade Setups - Newser
How to use a screener to detect Exagen Inc. breakoutsJuly 2025 Action & AI Enhanced Trading Alerts - Newser
Comparing Exagen Inc. in custom built stock radarsTrend Reversal & Entry and Exit Point Strategies - Newser
Exagen Inc. stock daily chart insightsEarnings Beat & Reliable Trade Execution Plans - Newser
Multi Factor Analysis Ranks Exagen Inc. as Strong Buy getLinesFromResByArray error: size == 0 - kangso.co.kr
Is Exagen Inc. reversing from oversold territoryJuly 2025 WrapUp & Daily Profit Focused Stock Screening - Newser
Building trade automation scripts for Exagen Inc.Product Launch & Real-Time Stock Movement Alerts - Newser
Is There Enough Volume to Lift Exagen Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Applying chart zones and confluence areas to Exagen Inc.July 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser
Finanzdaten der Exagen Inc-Aktie (XGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):